LIVE — 21:01 ET
Top Strategies #1 SMR Build Out 481.2% #2 AI Cooling Power Infra 335.8% #3 Quantum Compute Pure Play 459.2% #4 Silicon Photonics Optical 384.6% #5 Core Satellite 255.4% #6 Momentum 218.6% #7 AI Mega Ecosystem (Combined) 247.3% #8 Concentrate Winners 177.6% All strategies →
BETAExperimental layout — view production →
ASKMELON ARTICLES

Waste Management trades at 31x earnings while 2026 growth rides almost entirely on price, not volume

Waste Management is the bond-proxy industrial America loves to own — a recession-proof toll on the garbage every household and factory must throw away, compounding dividends for two decades. But the Q1 2026 numbers, reported in late April, expose what the premium is actually paying for. Operating revenue of $6.227 billion missed Wall Street's $6.287 billion target even as adjusted EPS of $1.81 sailed past the $1.70 estimate — a tell that the beat came from margin and buybacks, not from the top line. The full-year guidance is more telling still: core price of 5.4% to 5.8%, but volume of just 0.2% to 0.6%. WM is raising prices roughly ten times faster than it is moving more trash. Layer on a $7.2 billion Stericycle healthcare-waste acquisition that pushed leverage toward 3.6x, a recycling-and-renewable-gas capital program the market has already capitalized as growth, and a trailing P/E near 31 — about half again the waste-industry median — and you have a defensive compounder priced for an offensive decade.

· ← All articles

There is a particular kind of stock that institutional investors describe with a sigh of relief rather than a surge of excitement. Waste Management is the archetype. You cannot offshore the garbage. You cannot disrupt the landfill with software. Every restaurant, hospital, subdivision, and steel mill in North America generates waste that someone, by law and by physics, must come collect, and WM owns more of the irreplaceable landfill capacity that waste eventually lands in than anyone else on the continent. This is a genuinely excellent business, and nothing in what follows is an argument that it is not. The argument is narrower and more uncomfortable: that the market has decided to pay a growth-stock price for a toll-road asset, and that the toll is being raised on a customer base that is barely growing at all. At roughly 31 times trailing earnings — more than fifty percent above the waste-industry median near 20 — WM is priced as though the next decade will look like an inflection. The most recent quarter suggests it looks more like a treadmill set to a steeper incline.

The growth is price, and the price is almost all of it

Start with the number that the company itself volunteers, because it is the load-bearing beam of the entire thesis. For full-year 2026, WM guided to core price of 5.4% to 5.8%, yield of 3.2% to 3.6%, and volume of 0.2% to 0.6%. Read those three figures together slowly. Core price is the rate WM charges; volume is the amount of actual waste it handles. The company expects to raise its rate by more than five percent and grow the physical quantity of garbage it touches by, at the midpoint, under half a percent. The revenue line, in other words, is a pricing line wearing a growth costume.

This is not a scandal. It is what mature, capacity-constrained network businesses do, and disciplined pricing is a legitimate and durable source of value. But it changes what you are buying. A company growing revenue 5% on 5% volume is participating in an expanding market. A company growing revenue 5% on 0.4% volume is extracting more from a static one. The first deserves a growth multiple; the second deserves a quality-of-pricing multiple, which is a real and valuable thing but is not the same thing. The market is paying WM the former and being delivered the latter. When a defensive name is valued on the assumption that pricing power is both unlimited and permanent, the asymmetry runs against the buyer, because pricing power is the one variable that mean-reverts hardest the moment a customer finds an alternative or a regulator notices.

A revenue miss the beat papered over

The Q1 2026 print, reported in late April, is a small clinic in how this stock is read versus how it actually performed. Operating revenue came in at $6.227 billion against a consensus near $6.287 billion — a miss of roughly sixty million dollars. Adjusted diluted EPS landed at $1.81 versus the $1.70 estimate — a clean eleven-cent beat. The stock dipped on the report, which tells you the market noticed the top line even as the headlines led with the bottom one.

Here is why the gap matters forensically. When revenue misses and EPS beats, the beat is by definition coming from somewhere other than selling more. It comes from margin expansion, cost takeout, a lower share count after buybacks, a favorable tax line, or some combination. WM's adjusted operating EBITDA rose about 5.9% with margin expansion, and free cash flow nearly doubled on the quarter — genuinely strong, but it is the signature of an efficiency story, not a demand story. Management attributed part of the volume softness to severe winter weather depressing residential volumes, which is plausible and partly transitory. But weather is the kind of explanation that is true and convenient at the same time, and an investor paying 31 times earnings is entitled to ask how much of the volume stall is the calendar and how much is the structural reality that there is only so much trash, growing only so fast as the economy and population beneath it.

Stericycle: bought growth, borrowed balance sheet

The cleanest way to manufacture a top line when your organic volume is flat is to buy someone else's. In June 2024, WM announced the acquisition of Stericycle, the medical-waste and secure-information-destruction company, for $7.2 billion including roughly $1.4 billion of Stericycle's net debt. The deal created a new reporting segment, WM Healthcare Solutions, and gave WM a foothold in regulated medical waste — a business with real barriers and recurring revenue. On paper, a sensible adjacency.

Look at what it did to the balance sheet, though. WM expected net debt to EBITDA of roughly 3.4x immediately after closing, with a stated intention to work back down toward its 2.75x–3.0x target about eighteen months out. In practice, leverage moved to approximately 3.6x. For a company whose entire investment appeal is bond-like stability, a meaningful step-up in leverage is not a footnote — it is a change in the risk profile of the very thing you bought the stock for. And the integration has not been frictionless. The Healthcare Solutions segment hit turbulence tied to Stericycle's ERP system conversion and customer churn; management has guided to roughly 3% revenue growth for that business in 2026, again driven mainly by price. So the acquisition that was supposed to add a growth leg is, at least in its early innings, contributing a low-single-digit, price-led growth rate of its own — purchased with several billion dollars of incremental debt. The synergy target of more than $125 million in annual run-rate savings is real and achievable, but synergies are a cost story, and the market has been told a growth story.

The denominator illusion in "free cash flow nearly doubled"

When a company reports free cash flow that "nearly doubled" year over year, the instinct is to applaud. The discipline is to ask what the prior-year denominator was and what is sitting in the current-year numerator. WM's cash from operations was about $1.5 billion in the quarter, up roughly 24% year over year — a strong number. But free cash flow is operating cash flow minus capital expenditures, and the size of the year-over-year leap depends heavily on the timing and weight of capex, which for WM is lumpy precisely because of the recycling-automation and renewable-natural-gas build-out the company is in the middle of.

That matters because a doubling driven partly by a lighter capex quarter, or by favorable working-capital timing, is not the same as a doubling driven by sustainably higher cash generation. Neither the bull nor the bear should treat a single quarter's free-cash-flow growth rate as a trend. The honest read is that WM is a strong, reliable cash generator whose reported growth rate in any given quarter can be flattered or depressed by where it happens to be in a multi-year capital cycle. At 31 times earnings, the market is implicitly extrapolating the flattering quarters. The kicker is that the heaviest capital spending on RNG and recycling is precisely what the bull case also wants you to capitalize as future growth — you cannot both count the spend as the source of tomorrow's earnings and ignore it when it depresses today's free cash flow.

Recycling and renewable gas: optionality already on the meter

WM is building out renewable natural gas facilities that capture methane from its landfills and sell it, and automating recycling plants to lift their economics. CEO Jim Fish has pointed to six more RNG projects and four recycling projects due to come online in 2026, with sustainability investments described as having paid off in 2025. This is, in the abstract, the most genuinely interesting part of the WM story. Landfill methane is a free feedstock; turning a liability into a revenue stream is exactly the kind of structural edge that justifies a premium.

The forensic problem is not whether the projects work. It is that the market appears to have already capitalized the upside into the multiple before the cash shows up. RNG economics depend on environmental credit prices — federal RIN values and state low-carbon-fuel-standard credits — that are set by policy, not by WM, and that have historically been volatile. A revenue stream whose unit price is determined by a regulatory regime is a price-taker dressed as an annuity. When a company trades at a premium that bakes in a high-margin, policy-sensitive optionality at full value, any softening in credit prices, any delay in the project schedule, or any change in the subsidy framework comes straight out of a multiple that left no room for it. The optionality is real. The price already assumes it is realized.

Cyclical edges priced as if they were secular

Part of the bull case for 2026 is an organic re-acceleration — industrial volumes recovering, residential weather headwinds fading, healthcare stabilizing, RNG ramping. Each of those is plausible. But notice what kind of recovery it is. Industrial waste volume tracks construction, manufacturing, and demolition activity, which are cyclical. Residential "headwinds fading" is a weather and comparison effect, which is transitory by nature. These are the levers of a company whose volume is tethered to the real economy's cycle — which is fine, except that the valuation treats the recovery as a permanent step-change rather than a cyclical wiggle around a low-single-digit secular volume trend.

This is the recurring trap in defensive-industrial stocks: the cyclical upswing arrives, the multiple expands as if the upswing is the new baseline, and then the cycle does what cycles do. WM's secular volume growth is structurally tied to population and economic output, both of which compound in the low single digits at best. Any quarter where volume runs hot is borrowing from the mean; any quarter where it runs cold, the company reaches for weather. A buyer at 31 times earnings is paying for the hot quarters to be the rule.

The multiple is the whole argument

Strip away every individual frame and the thesis reduces to one comparison. WM trades around 31 times trailing earnings and roughly 27 times forward, against a waste-industry median in the low 20s — a premium of better than 50% on the trailing figure. Its EV/EBITDA sits near 14. Its dividend yield is about 1.54%. For context, Republic Services, the closest comparable, has outperformed WM's stock over the trailing twelve months while trading at a somewhat lower earnings multiple, and over the past decade has compounded at a marginally higher annual rate.

What does a 50%-plus premium to the industry buy you? Scale, the best landfill network, and a deserved reputation for operational excellence — none of which is in dispute. But premiums are paid out of future returns, and a stock priced for perfection has a specific failure mode: it does not need to deliver bad news to disappoint, only to deliver merely-good news that the price already assumed. WM's own guidance — high-single-digit EPS growth, low-single-digit volume, mid-single-digit pricing — is solid. It is also entirely consistent with a stock that has run ahead of its fundamentals, where the next several years of operating success are needed simply to grow into the multiple rather than to expand it.

The yield that no longer cushions

For most of WM's history, the dividend was a meaningful part of the total-return case — a growing payout that put a floor under the stock. At a yield near 1.54%, that cushion has thinned considerably. The dividend still grows, and the company's cash generation comfortably supports it. But a 1.5% yield does not protect a holder from multiple compression the way a 3% or 4% yield once did. When the income component of a defensive stock shrinks to the size of a broad-market index yield, the investor is increasingly relying on capital appreciation from an already-elevated multiple — which is precisely the part of the return that a priced-for-perfection name is least likely to deliver. The defensive label remains; the defensive math has quietly weakened.

The CFO transition nobody is pricing

There is a quieter governance detail layered into the 2026 story: WM is navigating a chief financial officer transition at the same moment it is integrating its largest acquisition in years and managing a multi-year capital build. None of these things individually is alarming, and orderly succession is the mark of a well-run company. But a finance-leadership change overlapping with a leveraged integration and a heavy capex cycle is exactly the kind of moment when guidance becomes harder to underwrite and when the cushion for execution error shrinks. The bear does not need to allege that anything goes wrong; the point is that a stock priced for flawless execution is taking on a cluster of simultaneous transitions — new CFO, new healthcare segment, new energy assets — and pricing each as if it carries no incremental risk. Perfection priced into a moment of maximum operational complexity is precisely the asymmetry that punishes the buyer if even one of the three transitions slips a few quarters behind schedule.

What the bulls genuinely get right

The bear case here is about price, not about the business — and intellectual honesty requires saying plainly where the bulls are correct, because on the fundamentals they are correct about a great deal.

First, the moat is real and arguably widening. Permitting a new landfill in North America is a years-long, often impossible regulatory ordeal. WM's existing disposal network is a genuinely scarce asset that cannot be replicated, and that scarcity is what underwrites the very pricing power this article is wary of. Pricing power built on irreplaceable physical assets is the highest-quality kind there is, and WM has it.

Second, the pricing discipline is a feature, not a bug. Extracting 5%+ core price in a low-inflation environment is evidence of structural strength, not desperation. Many businesses would kill for the ability to raise rates faster than inflation while losing almost no customers. WM's customer retention through years of above-inflation increases is real proof of an inelastic demand curve.

Third, the sustainability investments are credible and could genuinely surprise to the upside. Monetizing landfill methane is close to free money at the margin, and if RIN and LCFS credit prices hold or rise, the RNG portfolio could throw off high-margin cash that the current model only partially reflects. The recycling automation is a sober, returns-driven program, not a green-marketing exercise. If WM converts these projects on schedule and credit prices cooperate, the bear's "already capitalized" worry could prove too cautious.

Fourth, Stericycle, for all its early integration friction, is a strategically sound entry into regulated medical waste — a sticky, recurring, barrier-protected business — and the $125 million-plus synergy target is conservative relative to what scale integrations of this kind usually deliver. Give the integration eighteen to twenty-four months and the Healthcare Solutions segment could look materially better than its current low-single-digit, price-led growth suggests.

Fifth, and most importantly, this is a fortress through a recession. When the cycle turns, WM's volumes wobble but its cash flows do not collapse, its dividend keeps growing, and its pricing holds. For an investor who values sleeping at night over maximizing return, paying up for that durability is a rational choice, not a mistake. The premium is high, but it is not unearned.

The kicker

None of the forensic frames above accuse WM of anything. There is no fraud here, no accounting trick, no hidden liability — only a magnificent toll-road business asked to behave like a growth stock by a market that has confused stability with acceleration. The whole case sits in the gap between two of the company's own guidance numbers: 5.4% to 5.8% core price, and 0.2% to 0.6% volume. WM is not growing the amount of garbage America makes; it is growing what it charges to take it away, leaning on a leveraged healthcare acquisition still finding its feet and a renewable-gas build-out the price already assumes will pay. At 31 times earnings, that is a wager that the rate increases never stop, the credits never fall, and the cycle never turns — a lot to ask of a stock people buy precisely so they never have to think about it.

The market is paying a growth multiple for the privilege of watching a flat pile of garbage get billed at a steeper rate every year, and the day the customers stop swallowing the increase is the day the premium stops being defensive and starts being the risk.

Disclaimer

This article is produced for informational and educational purposes only and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. All data cited reflects information available as of the publication time noted above. Market conditions may change materially between publication and when you read this. Past performance of any strategy referenced is not indicative of future results. Consult a qualified financial advisor before making investment decisions.

Related reading
FEATURE

Rollins Trades Near 50 Times Earnings on 6.6% Organic Growth as Bought Deals Pad the Topline

Rollins is one of the most beloved defensive compounders on the American market — the parent of Orkin, a pest-control machine whose customers pay every quarter to keep ants, termites, and rodents out …

FEATURE

Take-Two's $44 billion market cap is one game, one date, and a $7.4 billion hole

Take-Two Interactive sells the most anticipated product in entertainment history, and on paper it still loses money — $298.2 million of GAAP net loss in the fiscal year that just ended, sitting atop a…

FEATURE

National Grid books record £11.6bn capex and 78p EPS, but a £44bn debt load funds the dividend

National Grid's FY2026 scorecard reads like a defensive investor's dream: underlying operating profit up 9% to £5.7bn, underlying EPS up 8% to 78.0p, a CPIH-linked dividend bumped to 48.49p, and a £70…

FEATURE

Okta's growth halves to 11% while the GAAP-to-adjusted gap swallows half its profit

Okta sells trust for a living, and the market is quietly repricing how much of it remains. The identity vendor that once compounded revenue above fifty percent a year reported just eleven percent grow…